Researcher.Life Logo

Biopharmaceutics and Drug Disposition : Impact Factor & More

eISSN: 1099-081XpISSN: 0142-2782

Key Metrics

CiteScore
3.1
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
0.54
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Biopharmaceutics and Drug Disposition

Biopharmaceutics and Drug Disposition Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1980
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Biopharmaceutics and Drug Disposition ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Biopharmaceutics and Drug Disposition

Prediction of Human Serum Concentration-Time Profiles of Golimumab and Ustekinumab Using Pharmacokinetic Data From Common Marmosets With Assessment of Anti-Drug Antibodies.
  • 20 Jun 2026
  • Biopharmaceutics & drug disposition
Optimized GFR Estimation Equations for Chinese Neonates and Children: Development of New Models and Comparison With Existing Ones.
  • 3 Jun 2026
  • Biopharmaceutics & drug disposition
Pharmacokinetic Assessment of Atazanavir and Favipiravir Following Echinacea Supplementation: A Controlled Herb-Drug Interaction Investigation.
  • 30 May 2026
  • Biopharmaceutics & drug disposition
A Slowly Self-Emulsifying Delivery System of Sesamin With Improved Biopharmaceutical Properties.
  • 23 May 2026
  • Biopharmaceutics & drug disposition
Ointment for Topical Ocular Delivery of Voriconazole: Formulation Development, In-Vitro Characterization & In-Vivo Pharmacokinetic Assessment.
  • 16 Apr 2026
  • Biopharmaceutics & drug disposition
Corneal Targeted Mucoadhesive Emulsion for Prolonged Delivery of Voriconazole: Formulation Evaluation and Pharmacokinetic Assessment.
  • 11 Apr 2026
  • Biopharmaceutics & drug disposition
Prediction of Human Serum Concentration-Time Profiles of Golimumab and Ustekinumab Using Pharmacokinetic Data From Common Marmosets With Assessment of Anti-Drug Antibodies.
  • 20 Jun 2026
  • Biopharmaceutics & drug disposition
Optimized GFR Estimation Equations for Chinese Neonates and Children: Development of New Models and Comparison With Existing Ones.
  • 3 Jun 2026
  • Biopharmaceutics & drug disposition
Pharmacokinetic Assessment of Atazanavir and Favipiravir Following Echinacea Supplementation: A Controlled Herb-Drug Interaction Investigation.
  • 30 May 2026
  • Biopharmaceutics & drug disposition
A Slowly Self-Emulsifying Delivery System of Sesamin With Improved Biopharmaceutical Properties.
  • 23 May 2026
  • Biopharmaceutics & drug disposition
Ointment for Topical Ocular Delivery of Voriconazole: Formulation Development, In-Vitro Characterization & In-Vivo Pharmacokinetic Assessment.
  • 16 Apr 2026
  • Biopharmaceutics & drug disposition
Corneal Targeted Mucoadhesive Emulsion for Prolonged Delivery of Voriconazole: Formulation Evaluation and Pharmacokinetic Assessment.
  • 11 Apr 2026
  • Biopharmaceutics & drug disposition

FAQs on Biopharmaceutics and Drug Disposition